(Circulation. 2000;101:2424.)
© 2000 American Heart Association, Inc.
Basic Science Reports |
From the Experimental Cardiology Laboratory, Cardiovascular Division, Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, Va, and Cis-bio international, Gif sur Yvette, France (R.P.).
Correspondence to David K. Glover, ME, Cardiovascular Division, Department of Medicine, Box 500, Medical Center, University of Virginia Health Sciences Center, Charlottesville, VA 22908. E-mail dglover{at}virginia.edu
BackgroundN-Ethoxy-N-ethyl-dithiocarbamato-nitrido-99mTc (99mTc-N-NOET) is a new neutral lipophilic 99mTc-labeled myocardial perfusion agent with a high first-pass extraction fraction and delayed redistribution kinetics after transient ischemia comparable to what is observed with 201Tl. It is unknown whether the uptake of this tracer reflects myocardial viability or just reperfusion flow in the setting of a reperfused myocardial infarction.
Methods and ResultsIn 13 anesthetized open-chest dogs, the left anterior descending coronary artery was occluded for 180 minutes, followed by 180 minutes of reperfusion. 201Tl and 99mTc-N-NOET were injected after either 60 (group 1, n=9) or 175 (group 2, n=4) minutes of reperfusion. Myocardial blood flow was measured by radioactive microspheres, and 201Tl and 99mTc-N-NOET tissue activities were determined by gamma-well counting. Normalized myocardial blood flow in the central infarct zone fell from 0.80±0.03 (SEM) and 0.89±0.01 at baseline to 0.18±0.04 and 0.13±0.02 during the occlusion in groups 1 and 2, respectively. Normalized 201Tl activity in these segments was 0.39±0.04 and 0.43±0.04 and reflected myocardial viability rather than reperfusion flow (P<0.001). Normalized 99mTc-N-NOET activity in the same segments was 0.84±0.08 and 0.64±0.03, respectively (P<0.01 versus 201Tl; P=NS versus reperfusion flow) and more accurately reflected reperfusion flow (0.99±0.17 and 0.70±0.04) than residual viability.
ConclusionsThe myocardial uptake of 99mTc-N-NOET reflects reperfusion myocardial blood flow and not viability in a canine model of reperfused acute myocardial infarction. The clinical use of early 99mTc-N-NOET imaging to assess the success of coronary reperfusion in patients with acute myocardial infarction should be investigated.
Key Words: radioisotopes myocardial infarction thallium technetium
This article has been cited by other articles:
![]() |
L. M. Riou, S. Unger, M.-C. Toufektsian, M. Ruiz, D. D. Watson, G. A. Beller, and D. K. Glover Effects of Increased Lipid Concentration and Hyperemic Blood Flow on the Intrinsic Myocardial Washout Kinetics of 99mTcN-NOET J. Nucl. Med., July 1, 2003; 44(7): 1092 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Riou, C. Ghezzi, G. Vanzetto, A. Broisat, J.-P. Mathieu, R. Bontron, R. Pasqualini, and D. Fagret Verapamil Does Not Inhibit 99mTcN-NOET Uptake In Situ in Normal or Ischemic Canine Myocardium J. Nucl. Med., June 1, 2003; 44(6): 981 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takehana, G. A. Beller, M. Ruiz, F. D. Petruzella, D. D. Watson, and D. K. Glover Assessment of Residual Coronary Stenoses Using 99mTc-N-NOET Vasodilator Stress Imaging to Evaluate Coronary Flow Reserve Early After Coronary Reperfusion in a Canine Model of Subendocardial Infarction J. Nucl. Med., September 1, 2001; 42(9): 1388 - 1394. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |